Cargando…
Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
Melanoma presents increasing prevalence and poor outcomes. Progression to aggressive stages is characterized by overexpression of the transcription factor E2F1 and activation of downstream prometastatic gene regulatory networks (GRNs). Appropriate therapeutic manipulation of the E2F1-governed GRNs h...
Autores principales: | Singh, Nivedita, Khan, Faiz M, Bala, Lakshmi, Vera, Julio, Wolkenhauer, Olaf, Pützer, Brigitte, Logotheti, Stella, Gupta, Shailendra K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666365/ https://www.ncbi.nlm.nih.gov/pubmed/37993971 http://dx.doi.org/10.1186/s13065-023-01082-2 |
Ejemplares similares
-
Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease
por: Spitschak, Alf, et al.
Publicado: (2022) -
An integrative network-driven pipeline for systematic identification of lncRNA-associated regulatory network motifs in metastatic melanoma
por: Singh, Nivedita, et al.
Publicado: (2020) -
STAT3 and STAT5 Targeting for Simultaneous Management of Melanoma and Autoimmune Diseases
por: Logotheti, Stella, et al.
Publicado: (2019) -
Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signatures
por: Khan, Faiz M., et al.
Publicado: (2017) -
MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance
por: Lai, Xin, et al.
Publicado: (2018)